Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Therapeutic Targeting of the Tumour Microenvironment in Post-Transplant Lymphoproliferative Disorder
FY 2023-24
Summary
A complication of solid organ or bone marrow transplantation is a form of lymphoma called 'post-transplant lymphoproliferative disorder', also known as PTLD. In general, patients who receive transplants also take drugs to suppress their bodies immune systems; otherwise their immune cells will recognize the transplant as foreign and attack it. The suppression of the immune system allows for lymphoma cells to go undetected by immune cells that would normally eliminate them, thus leading to the development of PTLD. Current treatments for PTLD are extremely toxic, and patients who do not respond to these treatments have poor survival. Therefore, new therapeutic strategies for PTLD are desperately needed. Tumours are complex systems of different cell types, including cancer cells and tumour-infiltrating immune cells. These cells can interact and communicate, and in doing so, cancer cells can influence the activity of nearby immune cells to suppress their anti-cancer functions. I propose that targeting the interactions between lymphoma cells and immune cells can be an effective therapeutic strategy for PTLD. My primary goal is to identify the biologically meaningful interactions between cancer cells and immune cells in PTLD. My secondary goal is to test drugs that block these interactions in laboratory models of PTLD called patient-derived organoids that effectively mimic the original tumours. I believe that my project will uncover better strategies to treat PTLD and ultimately improve patient outcomes.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
506582
Name
Zhao Davidson Z
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Therapeutic Targeting of the Tumour Microenvironment in Post-Transplant Lymphoproliferative Disorder
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cancer Genomics; Cell-Cell Interactions; Computational Biology; Tumour Microenvironment
Abstract
A complication of solid organ or bone marrow transplantation is a form of lymphoma called 'post-transplant lymphoproliferative disorder', also known as PTLD. In general, patients who receive transplants also take drugs to suppress their bodies immune systems; otherwise their immune cells will recognize the transplant as foreign and attack it. The suppression of the immune system allows for lymphoma cells to go undetected by immune cells that would normally eliminate them, thus leading to the development of PTLD. Current treatments for PTLD are extremely toxic, and patients who do not respond to these treatments have poor survival. Therefore, new therapeutic strategies for PTLD are desperately needed. Tumours are complex systems of different cell types, including cancer cells and tumour-infiltrating immune cells. These cells can interact and communicate, and in doing so, cancer cells can influence the activity of nearby immune cells to suppress their anti-cancer functions. I propose that targeting the interactions between lymphoma cells and immune cells can be an effective therapeutic strategy for PTLD. My primary goal is to identify the biologically meaningful interactions between cancer cells and immune cells in PTLD. My secondary goal is to test drugs that block these interactions in laboratory models of PTLD called patient-derived organoids that effectively mimic the original tumours. I believe that my project will uncover better strategies to treat PTLD and ultimately improve patient outcomes.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Zhao, Davidson Z
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~